MPM ASSET MANAGEMENT LLC - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 25 filers reported holding TCR2 THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
MPM ASSET MANAGEMENT LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$6,076,298
+50.2%
4,050,8650.0%2.53%
+49.6%
Q4 2022$4,046,814
-44.5%
4,050,8650.0%1.69%
-39.0%
Q3 2022$7,292,000
-37.9%
4,050,8650.0%2.78%
-44.0%
Q2 2022$11,748,000
+5.1%
4,050,8650.0%4.96%
+29.7%
Q1 2022$11,180,000
-40.8%
4,050,8650.0%3.82%
-6.3%
Q4 2021$18,877,000
-45.2%
4,050,8650.0%4.08%
-48.9%
Q3 2021$34,473,000
-48.1%
4,050,8650.0%7.99%
-35.4%
Q2 2021$66,475,000
-25.7%
4,050,8650.0%12.36%
-28.5%
Q1 2021$89,443,000
-28.6%
4,050,8650.0%17.28%
-2.5%
Q4 2020$125,293,000
+52.2%
4,050,8650.0%17.73%
+15.5%
Q3 2020$82,314,000
+32.3%
4,050,8650.0%15.35%
-17.1%
Q2 2020$62,221,000
+98.4%
4,050,8650.0%18.51%
-2.9%
Q1 2020$31,354,000
-45.8%
4,050,8650.0%19.07%
-25.1%
Q4 2019$57,846,000
-5.0%
4,050,8650.0%25.46%
-2.3%
Q3 2019$60,885,000
+5.0%
4,050,8650.0%26.06%
+11.2%
Q2 2019$57,968,000
-17.9%
4,050,8650.0%23.42%
-19.5%
Q1 2019$70,607,0004,050,86529.12%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$11,748,0004.96%
MPM BioImpact LLC 3,370,982$9,776,0002.72%
TANG CAPITAL MANAGEMENT LLC 3,641,606$10,561,0001.60%
Newtyn Management, LLC 692,799$2,009,0000.38%
K2 PRINCIPAL FUND, L.P. 1,078,070$3,126,0000.34%
HARBOR CAPITAL ADVISORS, INC. 64,341$187,0000.14%
Redmile Group, LLC 1,094,645$3,174,0000.12%
Artal Group S.A. 750,000$2,175,0000.12%
Oasis Management Co Ltd. 200,000$580,0000.10%
X-Square Capital, LLC 31,919$93,0000.06%
View complete list of TCR2 THERAPEUTICS INC shareholders